Table 1.
Baseline data, symptoms and routine CSF analyses
| |
Longitudinal study |
Cross-sectional study |
|||
|---|---|---|---|---|---|
| LNB | LNB | HIV | Controls | ||
|
N |
25 |
16 |
27 |
39 |
|
|
M/F |
17/8 |
7/9 |
16/11 |
17/22 |
|
|
Age (years) |
50 |
37 |
38 |
64 |
|
| (12–74) |
(25–67) |
(23–76) |
(27–76) |
||
|
Duration of symptoms (days) |
28 |
21 |
na |
na |
|
| (5–360) |
(7–120) |
||||
|
Symptoms |
|
|
|
|
|
| radiculitis |
15 |
10 |
na |
na |
|
| headache |
|
4 |
na |
na |
|
| facial palsy |
3 |
|
na |
na |
|
| radiculitis and facial palsy |
|
1 |
na |
na |
|
| radiculitis and other palsy |
2 |
1 |
na |
na |
|
| radiculits and sensibility disturbancies |
3 |
|
na |
na |
|
| other palsy |
2 |
|
na |
na |
|
| |
Baseline |
Follow-up |
|
|
|
|
CSF mononuclear cells (cells/μL) |
118 |
13 |
58 |
4 |
1 |
| (14–590) |
(2–21) |
(8–493) |
(0–69) |
(0–8) |
|
|
CSF albumin (mg/L) |
664 |
301 |
432 |
203 |
230 |
| (267–2108) |
(146–707) |
(206–1080) |
(108–383) |
(43–465) |
|
|
Blood CD4 cells (cells/μL) |
na |
na |
250 |
na |
|
| (20–940) | |||||
|
Blood viral count (copies/μL) |
na |
na |
54500 |
na |
|
| (2920–450000) | |||||
| CSF viral count (copies/μL) | na | na | 5680 |
na | |
| (0–384000) | |||||
Baseline data, clinical symptoms and routine CSF analyses for the longitudinal and the cross-sectional study. Data are presented as median (range). LNB – Lyme neuroborrelios, na – not applicable, other palsy – palsy other than facial palsy.